Equites Radar

HUM · Humana Inc.

Healthcare PlansUnited StatesAnalyst view: Buy

$409.80

+2.26% last session

End-of-day data · close of 2026-09-11

Bullish5 bullish · 0 bearish technical signals
Consensus: Buy (2.19 from 23 analysts)
To mean target: +4.5%

Market cap

$48B

Enterprise value

$39B

Trailing P/E

38.0

Forward P/E

24.2

Dividend yield

1.0%

Beta

0.74

Avg volume

1M

Employees

67K

Daily Change %

2.26%

5 Days Change

-0.38%

10 Days Change

4.38%

30 Days Change

7.30%

60 Days Change

1.99%

Month to Day Change

1.30%

Year to Day Change

57.34%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.19
Covering analysts23
Mean price target$418.61
Low price target$280.00
Upside to mean target+4.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)63.3
50-day MA$389.03
200-day MA$282.24
Price vs 50-day MA+5.3%
Price vs 200-day MA+45.2%
MACD histogram1.50
Volume vs 3-month avg0.5×
52w low $162.4652w high $409.80

Analyst sentiment over time — HUM

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-10

Latest call per bank · past 12 months

JP Morgan

Neutral

$393

-1.9% vs price
▲ raised from $316Maintains · 2026-08-10

Morgan Stanley

Equal-Weight

$370

-7.7% vs price
▲ raised from $249Upgrade · 2026-08-05

Barclays

Equal-Weight

$407

+1.6% vs price
▲ raised from $344Maintains · 2026-07-31

UBS

Neutral

$405

+1.1% vs price
▲ raised from $320Maintains · 2026-07-30

Wells Fargo

Overweight

$502

+25.3% vs price
▲ raised from $227Upgrade · 2026-07-13

RBC Capital

Sector Perform

$415

+3.6% vs price
▲ raised from $246Maintains · 2026-07-09

Bank of America

Neutral

$380

-5.2% vs price
▲ raised from $340Maintains · 2026-06-24

Deutsche Bank

Buy

$441

+10.0% vs price
▲ raised from $235Upgrade · 2026-05-20

Goldman Sachs

Sell

$158

-60.6% vs price
▼ cut from $215Maintains · 2026-02-17

Jefferies

Buy

$235

-41.4% vs price
▼ cut from $310Maintains · 2026-02-12

Recent rating actions

DateFirmActionRatingPrice target
2026-08-10JP MorganMaintainsNeutral$316 $393
2026-08-05Morgan StanleyUpgradeUnderweightEqual-Weight$249 $370
2026-07-31TD CowenMaintainsHold$350 $370
2026-07-31BarclaysMaintainsEqual-Weight$344 $407
2026-07-30UBSMaintainsNeutral$320 $405
2026-07-30Evercore ISI GroupUpgradeIn-LineOutperform$430 $480
2026-07-30GuggenheimMaintainsBuy$269 $471
2026-07-30Raymond JamesDowngradeOutperformMarket Perform$0.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.3% above the 50-day MA ($389.03).
  • Price vs 200-day MA: Trading 45.2% above the 200-day MA ($282.24).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is positive (+1.50) — short-term momentum is improving.
  • 52-week range: Price is within 5% of the 52-week high ($409.80).

HUM Price Chart

Loading chart for HUM

Fundamentals

Revenue (TTM)$146B
EBITDA$4.0B
Free cash flow$2.0B
Operating cash flow$3.0B
Book value / share$160.00
Net Debt / EBITDA-2.5
WACC8.0%
Revenue growth26.00%
Earnings growth27.00%

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

More in Healthcare Plans

Screen HUM against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.